| خلاصه مقاله | Background
Breast cancer is the most common malignancy in women worldwide, despite great advances in the diagnosis and treatment of cancer. Nowadays, with the advances in the bioinformatics analysis of RNAseq, it can identify potential biomarkers for diagnosis, treatment, and evaluation of metastasis and relapse. In this study, we are going to evaluate RNAseq data obtained from TCGA in breast cancer (BRCA) and investigate prognostic and protective genes in survival.
Method
GEPIA2 (http://gepia2.cancer-pku.cn/) was used to examine the TCGA BRCA dataset in order to identify all DEGs linked with BRCA among high throughput RNA-Seq data. GEPIA2 is an online program that uses the Genotype-Tissue Expression projects and the TCGA database to evaluate the transcriptional patterns of human malignancies and normal tissues. Genes with adj-P-value < 0.05 were considered significant; after that, significant genes were divided into 4 groups including up/down prognostic or protective genes according to the logFC and HR. After that, a Protein-protein interaction (PPI) network of significant genes associated with BRCA was constructed with STRING at the Cytoscape software.
Result
of 3556 genes acquired from TCGA-RNAseq for AML, 334 genes are considered significant; of which 127 genes are prognostic and 207 genes are protective. PPI networks were drawn for significant and also hub genes; according to the result, 7 genes are considered as hub genes based on their interaction and degree including CXCL1, SELL, CXCL9, CD3E, CCL5, CXCR3, and CCR5 (degree more than 20). All genes were protective (adj p-value < 0.05, HR <1).
Conclusion
This study identifies hub genes as a promising prognostic, protective, and diagnostic biomarker for breast cancer. Further investigations are warranted to identify the diagnostic potential of these genes. |